New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 22, 2014
06:54 EDTAMAGAMAG Pharmaceuticals to host conference call
Conference call to provide a regulatory update will be held on January 22 at 7:30 am. Webcast Link
News For AMAG From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
June 29, 2015
12:10 EDTAMAGAMAG acquisition of Cord Blood Registry a strong fit, says Leerink
Subscribe for More Information
07:39 EDTAMAGAMAG Pharmaceuticals to host conference call
Conference call to discuss acquisition of Cord Blood Registry will be held on June 29 at 8 am. Webcast Link
07:02 EDTAMAGAMAG Pharmaceuticals to acquire Cord Blood Registry for $700M
AMAG Pharmaceuticals announced that it has entered into a definitive agreement to acquire Cord Blood Registry, or CBR, the world's largest stem cell collection and storage company serving pregnant women and their families, for $700M. The acquisition of CBR would expand AMAG's suite of maternal health offerings and add a high-margin business with complementary commercial capabilities and attractive future growth opportunities to the AMAG portfolio. The transaction is expected to further diversify AMAG's revenue base, be immediately accretive to adjusted EBITDA and earnings, and result in expense synergies of approximately $15M annually. CBR's revenue consists of upfront processing revenues for newly stored units, as well as a high-margin recurring revenue based on cumulative stored units. CBR's growing base of installed units provides for an increasing mix of revenue from storage fees. The larger and more diversified forecasted revenues that we expect as a result of this transaction are projected to allow AMAG to achieve a lower overall cost of capital, with terms that provide more flexibility and borrowing capacity to consummate future transactions. The transaction has been unanimously approved by AMAG's and CBR's boards. It is anticipated that the transaction will close in Q3.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use